COVID-19/Coronavirus
Neurologic Manifestations Seen in Most Hospitalized With COVID-19
WEDNESDAY, Oct. 7, 2020 (HealthDay News) — Neurologic manifestations are common in COVID-19, occurring in 82.3 percent of hospitalized patients, according to a study published online Oct. 5 in the Annals of Clinical and Translational Neurology. Eric M. Liotta, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues characterized neurologic manifestations,...
Lopinavir-Ritonavir No Benefit in Patients Admitted With COVID-19
WEDNESDAY, Oct. 7, 2020 (HealthDay News) — Lopinavir-ritonavir is not associated with reductions in 28-day mortality or duration of hospital stay among patients admitted to the hospital with COVID-19, according to a study published online Oct. 5 in The Lancet. Peter W. Horby, M.D., Ph.D., and colleagues on behalf of the RECOVERY Collaborative Group conducted...
Review: Estimated Prevalence of VTE 14.1 Percent in COVID-19
WEDNESDAY, Oct. 7, 2020 (HealthDay News) — The overall prevalence of venous thromboembolism (VTE) in patients with COVID-19 is estimated to be 14.1 percent, with a higher prevalence for patients in the intensive care unit (ICU), according to a review published online Sep. 25 in Research and Practice in Thrombosis and Haemostasis. Stephan Nopp, M.D.,...
Physician's Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 28 to Oct. 2, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. Primary Care Visits...
Older Adults Likely to Be Excluded From COVID-19 Trials
FRIDAY, Oct. 2, 2020 (HealthDay News) — Older adults are likely to be excluded from many COVID-19 clinical trials and all vaccine trials, according to a research letter published online Sept. 28 in JAMA Internal Medicine. Benjamin K.I. Helfand, from the University of Massachusetts Medical School in Worcester, and colleagues reviewed all COVID-19 treatment and...
Mortality Below 40 Percent for COVID-19 Patients Put on ECMO
FRIDAY, Oct. 2, 2020 (HealthDay News) — For patients with COVID-19 receiving extracorporeal membrane oxygenation (ECMO) support, mortality is below 40 percent, according to a study published online Sept. 25 in The Lancet. Ryan P. Barbaro, M.D., from the University of Michigan in Ann Arbor, and colleagues characterized epidemiology, hospital course, and outcomes for patients...
Antibodies Decrease With Time After COVID-19 Symptom Onset
FRIDAY, Oct. 2, 2020 (HealthDay News) — Antibodies decrease with time after COVID-19 symptom onset, according to a research letter published online Oct. 1 in Blood. Josée Perreault, Ph.D., from Héma-Québec in Montréal, and colleagues analyzed severe acute respiratory syndrome coronavirus 2 spike protein receptor binding domain (RBD) antibody titers from potential COVID-19 convalescent plasma...
GI Complications More Common in Critically Ill With COVID-19
THURSDAY, Oct. 1, 2020 (HealthDay News) — A higher rate of gastrointestinal complications, including mesenteric ischemia, occurs among critically ill patients with COVID-19 versus matched patients without COVID-19, according to a research letter published online Sept. 24 in the Journal of the American Medical Association. Mohamad El Moheb, M.D., from Massachusetts General Hospital in Boston,...
Number, Proportion of Pediatric COVID-19 Cases Rising in the U.S.
THURSDAY, Oct. 1, 2020 (HealthDay News) — Pediatric COVID-19 cases increased considerably from April to September in the United States, according to a study published online Sept. 29 in Pediatrics. Blake Sisk, Ph.D., from the American Academy of Pediatrics in Itasca, Illinois, and colleagues describe pediatric COVID-19 infection in the United States using data drawn...
More Medical News
